Literature DB >> 21870719

[Depression and cardiovascular diseases in the elderly].

Lucretia Angheel1, Rodica Ghiuru, Cristina-Maria Gavrilescu.   

Abstract

UNLABELLED: The aim of this study was to reveal if there are connections between depression and cardiovascular disease. MATERIAL AND
METHOD: We have studied 413 patients from Jorasti, Jud Galati on a two-years period (2008-2010). On these patients there was performed a careful history taking and they were physically examined (height, weight, body mass index, waist, blood pressure, heart rate). There was also performed an ECG (electrocardiogram), there were measured the levels of cholesterolemia, HDL-cholesterolemia, trygliceridemia and creatininemia. We used the Geriatric Depression Scale (GDS) in order to evaluate depression.
RESULTS: in these patients there was noticed a higher prevalence of dyslipidemias, obesity and depression in women. Out of the 46 women with mild and severe depression 32 are overweight, 7 have obesity, 29 a high cholesterol, 23 a high LDL-cholesterol; all of them had a high risk or the presence of cardiovascular disease.
CONCLUSIONS: Depression is an independent risk factor for producing a cardiovascular event; the level of cholesterol and of the blood preessure was higher in patients with severe depression, proving that the level of the cardiovascular risk factors increased with the severity of the depression. Treating the elderly, which often associate depression, makes necessary a careful evaluation of all comorbidities and risks, in order to establish perfect individualized strategies of improving the quality of life.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870719

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  1 in total

1.  Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention.

Authors:  Xuefeng Lin; Aiqun Ma; Wei Zhang; Qun Lu; Chaofeng Sun; Hongyan Tian; Xinjun Lei; Xiaojun Bai
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.